ResMed Inc. (RMD)

ResMed Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	32,940	28,145	37,762	28,117	32,133	30,691
Market Cap Growth	-16.43%	-25.47%	34.31%	-12.50%	4.70%	-14.52%
Enterprise Value	32,297	27,327	37,669	29,025	33,617	31,303
Last Close Price	228.35	194.32	254.77	187.34	211.59	201.43

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PE Ratio	21.89	18.48	26.96	27.54	35.80	39.38
Forward PE	18.90	16.42	25.32	22.86	30.82	34.10
PS Ratio	5.83	4.98	7.34	6.00	7.61	8.58
PB Ratio	5.00	4.27	6.33	5.78	7.78	9.13
P/TBV Ratio	10.22	8.73	15.37	18.30	39.81	28.46
P/FCF Ratio	19.97	17.06	22.73	21.60	56.02	141.88
P/OCF Ratio	18.24	15.59	21.56	20.07	46.35	87.40
PEG Ratio	1.63	1.16	1.65	1.54	2.39	2.45

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
EV/Sales Ratio	5.71	4.83	7.32	6.20	7.96	8.75
EV/EBITDA Ratio	15.41	13.04	20.25	18.93	26.02	27.80
EV/EBIT Ratio	16.82	14.23	22.32	20.97	29.18	31.24
EV/FCF Ratio	19.58	16.57	22.67	22.30	58.60	144.71

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Debt / Equity Ratio	0.13	0.13	0.14	0.18	0.38	0.27
Debt / EBITDA Ratio	0.39	0.39	0.45	0.56	1.19	0.79
Debt / FCF Ratio	0.50	0.50	0.51	0.67	2.75	4.24
Net Debt / Equity Ratio	-0.10	-0.10	-0.06	0.13	0.33	0.19
Net Debt / EBITDA Ratio	-0.31	-0.31	-0.19	0.41	1.05	0.56
Net Debt / FCF Ratio	-0.39	-0.39	-0.21	0.49	2.36	2.93
Asset Turnover	0.66	0.66	0.68	0.69	0.71	0.73
Inventory Turnover	2.23	2.23	2.09	1.87	1.84	2.30
Quick Ratio	1.83	1.83	2.16	1.22	1.23	1.28
Current Ratio	3.10	3.10	3.44	2.59	3.12	2.80
Return on Equity (ROE)	24.27%	24.27%	25.86%	22.70%	23.96%	24.96%
Return on Assets (ROA)	14.00%	14.00%	14.02%	12.70%	12.15%	12.75%
Return on Invested Capital (ROIC)	26.23%	26.38%	25.36%	20.35%	19.81%	22.04%
Return on Capital Employed (ROCE)	25.40%	25.40%	23.60%	23.20%	19.20%	22.70%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Earnings Yield	4.62%	5.41%	3.71%	3.63%	2.79%	2.54%
FCF Yield	5.01%	5.86%	4.40%	4.63%	1.79%	0.70%
Dividend Yield	1.16%	1.23%	0.83%	1.03%	0.83%	0.83%
Payout Ratio	25.31%	22.95%	22.19%	27.65%	28.78%	31.48%
Buyback Yield / Dilution	0.87%	0.87%	0.14%	-0.06%	-0.28%	-0.40%
Total Shareholder Return	2.03%	2.11%	0.97%	0.96%	0.55%	0.43%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 5, 2026

Data Sources Report a data error